beta

VTL

Vital Therapies Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Vital Therapies Inc is a biotherapeutic company. The Company is engaged in developing a cell-based therapy targeting treatment acute forms of liver failure. Its product includes the ELAD System an extracorporeal bio-artificial liver support system.

Market Cap: 260 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.vitaltherapies.com

Shares Outstanding: 42.2 Million

Float: 41.5 Million

Dividend: 0.0 (0.0%)

Beta: 4.779428

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1277 trading days

From: 2014-06-16 To: 2019-04-12

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud